期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

血栓抽吸前替罗非班冠状动脉内注射在急性ST段抬高型心肌梗死患者中的应用 被引量：7

暂未订购
导出
摘要 急性心肌梗死的治疗目的是尽快开通罪犯血管,使心肌尽早完全恢复灌注。冠状动脉造影达TI-MI3级血流的患者中,有超过25%的患者心肌组织水平的血流并未恢复,脂质微粒等血栓脱落导致微栓塞、血小板激活及其所释放的血管活性物质导致的微循环功能障碍等等都是导致心肌未能充分再灌的原因[1]。作者使用抽吸导管联合替罗非班冠状动脉内注射治疗急性ST段抬高型心肌梗死患者,观察患者心功能的改变,现报道如下。
作者 娄唯鸣
机构地区 濮阳市油田总医院心内科
出处 《郑州大学学报（医学版）》 CAS 北大核心 2012年第6期870-873,共4页 Journal of Zhengzhou University(Medical Sciences)
关键词 急性心肌梗死 血栓抽吸 替罗非班 经皮冠状动脉介入治疗
分类号 R473.5 [医药卫生—护理学]
  • 相关文献

参考文献10

  • 1修建成,侯玉清,黄铮,郭志刚,周忠江,贾满盈,吴平生,许顶立.经皮冠状动脉介入术后支架内血栓对临床预后的影响[J].南方医科大学学报,2009,29(1):165-166. 被引量：5
  • 2高润霖.急性心肌梗死诊断和治疗指南[J].中华心血管病杂志,2001,29(12):710-725. 被引量：5257
  • 3Gibson CM,Cannon CP,Daley WL. TIMI frame count:a quantitative method of assessing coronary artery flow[J].Circulation,1996,(05):879.
  • 4Van Hof AW,Liem AL,Surapranata H. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction:myocardial blush grade[J].Circulation,1998,(23):2302.
  • 5Heitzer T,Ollmann L,Koke K. Platelet glycoprotein Ⅱb/Ⅲa receptor blockade improves vascular nitric oxide bioavailability in patients with coronary artery disease[J].Circulation,2003,(05):536.
  • 6Amoniucci D,Migliorini A,Parodi G. Abciximab-supported infarct artery stent implantation for acute myocardial infarction and long-term survival:a prospective,multicenter,randomized trial comparing infarct artery stenting plus abciximab with stenting alone[J].Circulation,2004,(14):1704.
  • 7Lefkovits J,Plow EF,Topol EJ. Platelet glycoprotein Ⅱb/Ⅲa receptor in cardiovascular medicine[J].New England Journal of Medicine,1995,(23):1553.
  • 8Kunichika H,Ben-Yehuda O,Lafitte S. Effects of glycoprotein Ⅱb/Ⅲa inhibition on microvascular flow after coronary reperfusion:a quantitative myocardial contrast echocardiography study[J].Journal of the American College of Cardiology,2004,(02):276.
  • 9Montalescot G,Borentain M,Payot L. Early vs late administration of glycoprotein Ⅱb/Ⅲ a inhibitors in primary percutaneous coronary intervention of acute ST segment elevation myocardial infarction:a meta analysis[J].Journal of the American Medical Association,2004,(03):362.
  • 10Montalescot G,Barragan P,Wittenberg O. Platelet glycoprotein Ⅱb/Ⅲa inhibition with coronary stenting for acute myocardial infarction[J].New England Journal of Medicine,2001,(25):1895.

二级参考文献10

  • 1调查协作组,霍勇.中国多中心药物洗脱支架急性或亚急性血栓的调查[J].中国介入心脏病学杂志,2005,13(3):131-134. 被引量：24
  • 2Moussa I. Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation [ J ]. Circulation, 1999, 99: 2364-6.
  • 3Schulen H, Kastrati A, Dirschinger J, et al. Intracoronary stenting and risk for major adverse cardiac events during the first month[J]. Circulation, 1998, 98:104-11.
  • 4Cheneau E, Leborgne L, Mintz GS, et al. Predictor of subacute stent thrombosis: result of a systematic intravascular ultrasound study [J]. Circulation, 2003, 108: 43-7.
  • 5Honda Y, Fitzgerald PJ. Stent thrombosis: an issue revisited in a changing world [ J ]. Circulation, 2003, 108: 2-5.
  • 6Kereiakes DJ. Coronary small-vessel stenting in the era of drug elution[J]. Rev Cardiovasc Med, 2004, 5 (Suppl 2): S34-45.
  • 7Kuchulakanti PK, Chu WW, Torguson R, et al. Correlates and longterm outcomes of angiographically proven stent thrombosis with sirolimus-and paclitaxel-eluting stents [J]. Circulation, 2006, 113: 1108-13.
  • 8Giuseppe GL, Biondi Z, Marzia L, et al. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50279 patients at risk for coronary artery disease [J ]. Eur Heart J, 2006, 27: 2667-74.
  • 9Montalescot G, Sideris G, Meuleman C, et al. A randomized comparison of high clopidogrel loading doses in patients with non-ST-segment elevation acute coronary syndromes: the ALBION(Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis) trial [J]. J Am Coil Cardiol, 2006, 48:931-8.
  • 10Pfisterer M, Brunner-La Rocca HP, Buser PT, et al. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents[ J]. J Am Coil Cardiol, 2006, 48: 2584-91.

共引文献5260

同被引文献59

  • 1Hernanides RS, Ottervanger JP, ten Berg JM, et al. Net clinical benefitof prehospital glycoprotein Ⅱb/Ⅲa inhibitors in patients with STelevationmyocardial infarction and high risk of bleeding: effectof tirofiban in patients at high risk of bleeding using CRUSADEbleeding score[J]. J Invasive Cardiol, 2012, 24(3): 84-89.
  • 2Subherwal S, Bach RG, Chen AY, et al. Baseline risk of majorbleeding in non- ST elevation myocardial infarction[J].Circulation, 2009, 119(14): 1873-1882.
  • 3Rao AK, Pratt C, Berke A, et al. Thrombolysis in myocardialinfarction (TIMI) trial-phase I: hemorrhagic manifestationsand changes in plasma fibrinogen and the fibrinolytic system inpatients treated with recombinant tissue plasminogen activatorand streptokinase[J]. J Am Coll Cardiol, 1988, 11(1): 1-11.
  • 4Scarborough RM, Kleiman NS, Philips DR. Platelet glycoproteinⅡb/Ⅲa Antagonists. What are the relevant issues concerningtheir pharmacology and clinical use[J]? Circulation, 1999,100(4): 437-444.
  • 5van Werkum JW, Gerritsen WB, Kelder JC, et al. Inhibition ofplatelet function by abciximab or high-dose tirofiban in patientswith STEMI undergoing primary PCI: a randomised trial[J].Neth Heart J, 2007, 15(11): 375-381.
  • 6Platelet receptor inhibition in ischemic syndrome management(PRISM) study investigators. A comparison of aspirin plustirofiban with aspirin plus heparin for unstable angina[J]. N EnglJ Med, 1998, 338(21): 1498-1505.
  • 7The PRISM-PLUS Study Investigators. Inhibition of the plateletglycoprotein Ⅱb/Ⅲa receptor with tirofiban in unstable anginaand non-Q-wave myocardial infarction[J]. N Eng J Med, 1998,338(21): 1488-1497.
  • 8The RESTORE Investigators. Effects of platelet glycoproteinⅡb/Ⅲa blockade with tirofiban on adverse cardiac events inpatients with unstable angina or acute myocardial infarctionundergoing coronary angioplasty[J]. Circulation, 1997, 96(5):1445-1453.
  • 9Kochman W, Dobrzycki S, Nowak KS, et al. Safety and feasibilityof a noval dosing regimen of tirofiban administered in patientswith acute myocardial infarction with ST elevation beforeprimary coronary angioplasty: a pilot study[J]. J ThrombThrombolysis, 2004, 17(2): 127-131.
  • 10Hermanides RS, Ottervanger JP, Dambrink JHE, et al. Risk ofbleeding after pre-hospital administration of high dose tirofibanfor ST-elevation myocardial infarction[J]. Int J Cardiol, 2012,157(1): 86-90.

引证文献7

二级引证文献75

郑州大学学报（医学版）
2012年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部